Skip to main content
Premium Trial:

Request an Annual Quote

NIH Now Says NIDDK Genomics Lab Not Yet Ready to Offer Microarray Services to All Institutes

NEW YORK (GenomeWeb News) — Correcting a statement it made last week, the Genomics Core Laboratory of the National Institute of Diabetes, Digestive and Kidney Diseases today said it has not begun providing its microarray services to all NIH institutes.
 
Last week, Genomics Core Director Margaret Cam said the extension is open-ended, unless the NIH decides to use other providers, and reflects greater fiscal responsiveness to budget demands within the NIH.  
 
In fact, the NIDDK “has been working on appropriate mechanisms for providing services but has not completed the process to date,” a second NIH official told GenomeWeb News today.
 
The message, sent by e-mail from a spokesperson for the NIH’s Office of the Scientific Director for the NIDDK Division of Intramural Research, added: “I believe that they are working on a mechanism for providing services, to others, but all the details haven't been worked out yet.”
 
The NIDDK Genomics Core currently uses Affymetrix and Codelink array platforms, and will offer its services to other NIH researchers for $400 per sample or $350 per sample for orders over 100 samples.
 
The service includes sample QC; automated target labeling; hybridization; preliminary statistical data analysis; storage and management of microarray data; online access to raw and processed data and GEO submission reports.
The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.